A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy-Reference-Cited by-同舟云学术

A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy

Published:2017-03-31 Issue:6 Volume:120 Page:774-781
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

van Leeuwen Pim J.¹²^ORCID,Hayen Andrew³,Thompson James E.¹²³,Moses Daniel⁴,Shnier Ron⁴,Böhm Maret²,Abuodha Magdaline²,Haynes Anne-Maree²,Ting Francis¹²³^ORCID,Barentsz Jelle⁵,Roobol Monique⁶,Vass Justin⁷,Rasiah Krishan⁷,Delprado Warick⁸,Stricker Phillip D.¹²³

Affiliation:

1. St. Vincent's Prostate Cancer Centre; Darlinghurst New South Wales Australia

2. Garvan Institute of Medical Research/The Kinghorn Cancer Centre; Darlinghurst New South Wales Australia

3. School of Public Health and Community Medicine; Kensington New South Wales Australia

4. School of Medicine; University of New South Wales; Kensington New South Wales Australia

5. Department of Radiology and Nuclear Medicine; Radboud University Medical Centre; Nijmegen the Netherlands

6. Department of Urology; Erasmus University Medical Center; Rotterdam the Netherlands

7. Department of Urology; Royal North Shore Private Hospital; St Leonards New South Wales Australia

8. Douglass Hanly Moir Pathology and University of Notre Dame; Darlinghurst New South Wales Australia

Funder

National Health and Medical Research Council

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13814/fullpdf

Reference32 articles.

1. American Cancer Society Inc Global Cancer Facts & Figures 2015 https://old.cancer.org/acs/groups/content/@editorial/documents/document/acspc-044552.pdf

2. Australia Government Cancer Australia Prostate cancer in Australia, 2015 https://prostate-cancer.canceraustralia.gov.au/statistics

3. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

4. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer;Draisma;J Natl Cancer Inst,2003

5. A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer;Roobol;Eur Urol,2010

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiomics from multisite MRI and clinical data to predict clinically significant prostate cancer;Acta Radiologica;2023-12-20

2. How prostate‐specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway;BJU International;2023-10-04

3. Performance of magnetic resonance imaging‐based prostate cancer risk calculators and decision strategies in two large European medical centres;BJU International;2023-09-12

4. Prostate cancer nomograms and their application in Asian men: a review;Prostate International;2023-08

5. A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy;European Urology Open Science;2023-07